[go: up one dir, main page]

WO2010032043A3 - Formulations - Google Patents

Formulations Download PDF

Info

Publication number
WO2010032043A3
WO2010032043A3 PCT/GB2009/051193 GB2009051193W WO2010032043A3 WO 2010032043 A3 WO2010032043 A3 WO 2010032043A3 GB 2009051193 W GB2009051193 W GB 2009051193W WO 2010032043 A3 WO2010032043 A3 WO 2010032043A3
Authority
WO
WIPO (PCT)
Prior art keywords
derivative
antimicrobial
containinga
dialkyl sulphosuccinate
acne
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2009/051193
Other languages
English (en)
Other versions
WO2010032043A2 (fr
Inventor
Scott Seville
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntopix Group PLC
Original Assignee
Syntopix Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0816876A external-priority patent/GB0816876D0/en
Priority claimed from GBGB0911213.7A external-priority patent/GB0911213D0/en
Application filed by Syntopix Group PLC filed Critical Syntopix Group PLC
Publication of WO2010032043A2 publication Critical patent/WO2010032043A2/fr
Publication of WO2010032043A3 publication Critical patent/WO2010032043A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225Polycarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne une formulation antimicrobienne et/ou anti-acnéique contenant (a) un sulfosuccinate de dialkyle (DAS) ou un dérivé de celui-ci et (b) un composé de formule (I) ou un dérivé de celui-ci : formule (I) dans laquelle R1 et R2 sont chacun indépendamment choisis parmi le méthyle et l'éthyle et R3 est un hydrogène. La formulation peut être utilisée pour traiter des affections telles que des affections de la peau et de la structure cutanée, en particulier l'acné. Elle peut particulièrement être utilisée en tant qu'agent antibactérien, plus particulièrement contre les propionibactéries.
PCT/GB2009/051193 2008-09-16 2009-09-15 Formulations Ceased WO2010032043A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0816876A GB0816876D0 (en) 2008-09-16 2008-09-16 Formulations
GB0816876.7 2008-09-16
GB0911213.7 2009-06-30
GBGB0911213.7A GB0911213D0 (en) 2009-06-30 2009-06-30 Formulation

Publications (2)

Publication Number Publication Date
WO2010032043A2 WO2010032043A2 (fr) 2010-03-25
WO2010032043A3 true WO2010032043A3 (fr) 2010-08-12

Family

ID=41277683

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2009/051193 Ceased WO2010032043A2 (fr) 2008-09-16 2009-09-15 Formulations

Country Status (2)

Country Link
GB (1) GB2463568B (fr)
WO (1) WO2010032043A2 (fr)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50140627A (fr) * 1974-04-25 1975-11-11
US4148872A (en) * 1977-11-28 1979-04-10 General Mills, Inc. Plaque inhibiting composition and method
WO1986007258A1 (fr) * 1985-06-05 1986-12-18 Meditech Pharmaceuticals, Inc. Procedes et agent anti-bacterien
US5082661A (en) * 1990-09-26 1992-01-21 Elizabeth Arden Co., Division Of Conopco, Inc. Odorless cosmetic compositions in gelatin capsules
US6855341B2 (en) * 2002-11-04 2005-02-15 Jeffrey B. Smith Anti-viral compositions and methods of making and using the anti-viral compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7104234A (fr) * 1970-05-11 1971-11-15
US20100273876A1 (en) * 2007-05-31 2010-10-28 Scott Seville antibacterial formulation comprising a dialkyl sulphosuccinate and a carbanilide antibacterial agent
GB2456376A (en) * 2008-12-22 2009-07-15 Syntopix Ltd Antibacterial/anti-acne formulations comprising a halogenated salicylanilide in combination with one or more anti-acne agents

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50140627A (fr) * 1974-04-25 1975-11-11
US4148872A (en) * 1977-11-28 1979-04-10 General Mills, Inc. Plaque inhibiting composition and method
WO1986007258A1 (fr) * 1985-06-05 1986-12-18 Meditech Pharmaceuticals, Inc. Procedes et agent anti-bacterien
US5082661A (en) * 1990-09-26 1992-01-21 Elizabeth Arden Co., Division Of Conopco, Inc. Odorless cosmetic compositions in gelatin capsules
US6855341B2 (en) * 2002-11-04 2005-02-15 Jeffrey B. Smith Anti-viral compositions and methods of making and using the anti-viral compositions

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
YOSHITOMI PHARMACEUTICAL INDUSTRIES LTD: "Disinfectants containing 2,2'-methylene bis (4-methyl-6-tert-butylphenol", CAPLUS,, 1 January 1976 (1976-01-01), pages 1 - 2, XP002480198 *
YU A ET AL: "Volatile phenolic derivatives and its role in Chinese traditional smoke-cured meat", CAPLUS, 17 October 2006 (2006-10-17), pages 1 - 3, XP002480199 *

Also Published As

Publication number Publication date
GB2463568A (en) 2010-03-24
GB0916106D0 (en) 2009-10-28
GB2463568B (en) 2010-07-07
WO2010032043A2 (fr) 2010-03-25

Similar Documents

Publication Publication Date Title
WO2007096601A3 (fr) Formules
WO2009074735A3 (fr) Utilisation d'un nouvel agent naturel dans des compositions cosmetiques
WO2012085523A3 (fr) Compositions désinfectantes pour la peau contenant une émulsion à base d'alcool
IL316851A (en) Preparations that are pharmaceutical emulsions for topical use containing 5,3-dihydroxy-4-isopropyl-trans-stilbene and their use for the treatment or prevention of dermatological conditions or disorders
WO2008131860A3 (fr) Pyridone-carboxamides, phytoprotecteurs contenant ces composés, procédés pour leur production et leur utilisation
WO2007110415A3 (fr) Utilisation de trimères diacétyliques et formulations cosmétiques ou thérapeutiques contenant ces composés
WO2008101682A3 (fr) Nouveaux microbiocides
WO2009106991A3 (fr) Dérivés de pyridazine et leur utilisation comme agents thérapeutiques
WO2011123623A3 (fr) Procédés antimicrobiens topiques pour la peau, les ongles et les cheveux utilisant des formulations contenant des composés quaternaires d'organosilane
MX354480B (es) Composiciones espumables de peróxido de benzoilo para administración tópica.
WO2012163928A3 (fr) Composition de lavage
WO2008070859A3 (fr) Traitement d'affections cutanées par dickkopf1 (dkk1)
HK1202448A1 (en) Topical formulation for administering a compound
WO2009016046A3 (fr) Compositions pour bronzage sans soleil
MX2009000420A (es) Derivados de isoindolina para el tratamiento de arritmias.
WO2011039444A3 (fr) Composition, utilisation et procédé de conservation
WO2010098600A3 (fr) Dérivés d'azole substitués, composition pharmaceutique contenant les dérivés et procédé de traitement de la maladie de parkinson à l'aide de ceux-ci
WO2009041663A1 (fr) Agent destiné à la prévention et/ou au traitement de maladies cutanées
WO2012040804A3 (fr) Combinaisons synergiques de triazoles, strobilurines et de benzimidazoles, leurs utilisations, formulations, leurs procédés de production et leurs applications
WO2010039654A3 (fr) Traitement topique d'une infection de la peau
EP2023724B8 (fr) Combinaisons de principes actifs ayant un effet de synergie
WO2012026813A3 (fr) Analogues de géranylgéranylacétone (gga) et leurs utilisations
WO2008107092A3 (fr) Utilisation de dérivés d'acide 4-hydroxyphénoxy acétique
WO2011046978A3 (fr) Composés stéroïdes en tant que modificateurs de la mélanogenèse et leurs utilisations
MX2014003449A (es) Heterociclocarbonilaminotiazoles, preparaciones cosmeticas o dermatologicas que contienen los mismos y su uso para el control y la profilaxis de pigmentacion indeseada de la piel.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09785647

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09785647

Country of ref document: EP

Kind code of ref document: A2